Axonics logo

Axonics

Sacral neuromodulation systems treating bladder and bowel dysfunction.

What they do

The company develops implantable, rechargeable sacral neuromodulation devices that deliver mild electrical stimulation to pelvic nerves. These systems are purchased by urology and gynecology clinics to treat overactive bladder and fecal incontinence.

The record

Vertical
Medical Devices
Sub-segment
Neuromodulation
Product type
Device
Stage
Public
Headquarters
Irvine, USA
Region
North America
Founded
2013
Total funding
$114M raised

Notable investors: Andera Partners, NeoMed Management, Legend Capital.

Also in Medical Devices

See the Medical Devices market map

Related on The Signal